Cell Secretome: Basic Insights and Therapeutic Opportunities for CNS Disorders

Area of Science:

• Neuroscience
• Regenerative Medicine
• Cell Biology

Background:

• Mesenchymal stem cells (MSCs) are explored for treating central nervous system (CNS) injuries and diseases.
• Focus is shifting towards using cell byproducts, specifically the MSC secretome, for therapeutic applications.

Purpose of the Study:

• To review the current applications of secretome-based therapies for CNS pathologies.
• To discuss secretome sources, composition, collection techniques, and therapeutic potential.
• To clarify existing questions regarding secretome-based therapies for clinical application in CNS disorders.

Main Methods:

• Literature review of studies on MSC secretome and its application in CNS disorders.
• Analysis of secretome composition, including protein and vesicular fractions.
• Examination of therapeutic effects on spinal cord injury (SCI), traumatic brain injury (TBI), ischemic stroke (IS), and Parkinson's disease (PD).

Main Results:

• The MSC secretome contains proteins and vesicles with therapeutic potential for CNS conditions.
• Different secretome fractions may exhibit varying therapeutic efficacies.
• Secretome-based approaches offer a promising alternative to cell transplantation for CNS repair.

Conclusions:

• Secretome-based therapies represent a significant advancement in regenerative medicine for CNS disorders.
• Further research is needed to optimize secretome collection and application for clinical use.
• Understanding the secretome's impact is crucial for developing effective treatments for SCI, TBI, IS, and PD.